The inhibitory effect of altered collagen II peptide on HLA-DRB1-restricted T-cell activation

Scandinavian Journal of Immunology

Volumn 61, Issue 3, 2005, Pages 260-265

  Cheng, Y J ^a   Zhou, Q ^a   Li, Z G ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; COLLAGEN TYPE 2; HLA DR ANTIGEN; T LYMPHOCYTE RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGENICITY; ARTICLE; ARTICULAR CARTILAGE; CELL PROLIFERATION; CRYSTAL STRUCTURE; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; IMMUNE RESPONSE; IMMUNIZATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NONHUMAN; PATHOGENESIS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; STRUCTURE ANALYSIS; T LYMPHOCYTE ACTIVATION; WILD TYPE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIGEN-PRESENTING CELLS; ARTHRITIS, RHEUMATOID; CELL LINE; COLLAGEN TYPE II; HLA-DR ANTIGENS; HUMANS; L CELLS (CELL LINE); LYMPHOCYTE ACTIVATION; MICE; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TRANSFECTION;

EID: 16244404933     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2005.01553.x     Document Type: Article

References (25)

1. Nepom GT, Byers P, Seyfried C et al. HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 1989;32:15-21.
2. Ohta N, Nishimura YK, Tanimoto K et al. Association between HLA and Japanese patients with rheumatoid arthritis. Hum Immunol 1982;5:123-32.
3. Deighton CM, Kelly PJ, Walker DJ. Linkage of rheumatoid arthritis with HLA. Ann Rheum Dis 1993;52:638-42.
4. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
5. Nepom GT. The role of the DR4 shared epitope in selection and commitment of autoreactive T cells in rheumatoid arthritis. Rheum Dis Clin North Am 2001;27:305-15.
6. Goldring SR, Gravallese EM. Pathogenesis of bone lesions in rheumatoid arthritis. Curr Rheumatol Rep 2002;4;226-31.
7. Kim HY, Kim WU, Cho ML et al. Enhanced T cell proliferative response to type II collagen and synthetic peptide II (255-274) in patients with rheumatoid arthritis. Arthritis Rheum 1999;42:2085-93.
8. Zhou Q, Mu R, He J et al. The effects of HLA-DRB1 specific hyporesponsive peptide on T cell activation in rheumatoid arthritis. Chin J Rheumatol 2003;7:324-7.
9. Zhou Q, Cheng YJ, Lu H, Zhou W, Li Z. Inhibition of T cell activation with HLA-DR1/DR4 restricted non-T cell stimulating peptides. Hum Immunol 2003;4 (9):857-65.
10. Rosloniec EF, Brand DD, Myers LK et al. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. J Immunol 2002;160:2573-8.
11. Andersson EC, Hansen BE, Jacobsen H et al. Definition of MHC and T cell receptor contacts in the HLA-DR1 restricted immudominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci USA 1998;95:7574-9.
12. Rosloniec EF, Brand DD, Myers LK et al. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med 1997;185:1113-22.
13. Fugger L, Rothbard JB, Sonderstrup-Mcdevitt G. Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen. Eur J Immunol 1996;26:928-33.
14. Dessen A, Lawrence CM, Cupo S et al. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 1997;7:473-81.
15. Zhou Q, Cheng YJ, Zhang XW et al. Inhibition of collagen-induced arthritis by HLA-DRB1 specific non-T cell binding peptides. Chin J Rheumatol 2002;6:397-9.
16. Rosloniec EF, Whittington KB, Zaller DM et al. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen. J Immunol 2002;168:253-9.
17. Fridkis-Hareli M, Rosloniec EF, Fugger L, Strominger JL. Synthetic amino acid copolymers that bind to HLA-DR proteins and inhibit type II collagen-reactive T cell clones. Proc Natl Acad Sci USA 1998;95:12528-31.
18. Stern LJ, Brown JH, Jardetzky TS et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994;368:215-21.
19. Fremont DH, Hendrickson WA, Marrack P et al. Structures of an MHC class II molecule with covalently bound single peptides. Science 1996;272:1001-4.
20. Fridkis-Hareli M, Strominger JL. Promiscuous binding of synthetic copolymer 1 to purified HLA-DR molecule. J Immunol 1998;160:4386-97.
21. Vergelli M, Hemmer B, Utz U et al. Differential activation of human autoreactive T cell clones by altered peptide ligand derived from myelin basic protein peptide (87-99). Eur J Immunol 1996;26:2624-34.
22. Prakken BJ, Roord S, van Kooten PJ et al. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope. Arthritis Rheum 2002;46:1937-46.
23. Diab BY, Lambert NC, L'Faqihi FE et al. Human collagen II peptide 256-271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis. Immunogenetics 1999;49:36-44.
24. Brand DD, Myers LK, Terato K et al. Characterization of T cell determinants in the induction of autoimmune arthritis by bovine α1(II)-CB11 in H-2q mice. J Immunol 1994;152:3088-97.
25. Rosloniec EF, Whittington KB, Brand DD et al. Identification of MHC class II and TCR binding residues in the type II collagen immunodominant determinant mediating collagen-induced arthritis. Cell Immunol 1996;172:21-8.